South Korea · Delayed Price · Currency is KRW T Scientific Statistics
Total Valuation
T Scientific has a market cap or net worth of KRW 27.32 billion. The enterprise value is 21.58 billion.
| Market Cap | 27.32B |
| Enterprise Value | 21.58B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
T Scientific has 15.79 million shares outstanding. The number of shares has increased by 0.45% in one year.
| Current Share Class | 15.79M |
| Shares Outstanding | 15.79M |
| Shares Change (YoY) | +0.45% |
| Shares Change (QoQ) | +2.25% |
| Owned by Insiders (%) | 0.30% |
| Owned by Institutions (%) | 0.01% |
| Float | 9.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.79 |
| PB Ratio | 0.16 |
| P/TBV Ratio | 0.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.63 |
| EV / EBITDA | 56.50 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.04.
| Current Ratio | 1.31 |
| Quick Ratio | 1.10 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 17.94 |
| Debt / FCF | -5.35 |
| Interest Coverage | -0.51 |
Financial Efficiency
Return on equity (ROE) is -0.88% and return on invested capital (ROIC) is -0.29%.
| Return on Equity (ROE) | -0.88% |
| Return on Assets (ROA) | -0.16% |
| Return on Invested Capital (ROIC) | -0.29% |
| Return on Capital Employed (ROCE) | -0.26% |
| Weighted Average Cost of Capital (WACC) | 5.09% |
| Revenue Per Employee | 151.13M |
| Profits Per Employee | -4.75M |
| Employee Count | 224 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 23.38 |
Taxes
| Income Tax | -3.25B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.36% in the last 52 weeks. The beta is -0.10, so T Scientific's price volatility has been lower than the market average.
| Beta (5Y) | -0.10 |
| 52-Week Price Change | -71.36% |
| 50-Day Moving Average | 1,675.84 |
| 200-Day Moving Average | 2,753.82 |
| Relative Strength Index (RSI) | 51.17 |
| Average Volume (20 Days) | 119,404 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, T Scientific had revenue of KRW 34.46 billion and -1.08 billion in losses. Loss per share was -75.85.
| Revenue | 34.46B |
| Gross Profit | 10.06B |
| Operating Income | -472.21M |
| Pretax Income | -4.63B |
| Net Income | -1.08B |
| EBITDA | 381.84M |
| EBIT | -472.21M |
| Loss Per Share | -75.85 |
Balance Sheet
The company has 12.48 billion in cash and 6.85 billion in debt, with a net cash position of 5.63 billion or 356.43 per share.
| Cash & Cash Equivalents | 12.48B |
| Total Debt | 6.85B |
| Net Cash | 5.63B |
| Net Cash Per Share | 356.43 |
| Equity (Book Value) | 171.59B |
| Book Value Per Share | 10,874.17 |
| Working Capital | 5.75B |
Cash Flow
In the last 12 months, operating cash flow was -1.04 billion and capital expenditures -235.04 million, giving a free cash flow of -1.28 billion.
| Operating Cash Flow | -1.04B |
| Capital Expenditures | -235.04M |
| Depreciation & Amortization | 854.05M |
| Net Borrowing | -462.89M |
| Free Cash Flow | -1.28B |
| FCF Per Share | -81.04 |
Margins
Gross margin is 29.20%, with operating and profit margins of -1.37% and -3.14%.
| Gross Margin | 29.20% |
| Operating Margin | -1.37% |
| Pretax Margin | -13.43% |
| Profit Margin | -3.14% |
| EBITDA Margin | 1.11% |
| EBIT Margin | -1.37% |
| FCF Margin | n/a |
Dividends & Yields
T Scientific does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.45% |
| Shareholder Yield | -0.45% |
| Earnings Yield | -3.96% |
| FCF Yield | -4.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 10, 2026. It was a reverse split with a ratio of 0.2.
| Last Split Date | Apr 10, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
T Scientific has an Altman Z-Score of 1.29 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.29 |
| Piotroski F-Score | 2 |